Review



control fibroblasts  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC control fibroblasts
    Cholesterol depletion promotes small extracellular vesicle release. (A) Cholesterol metabolic reactions targeted with small molecule inhibitors (red text). Rare diseases of cholesterol biosynthesis (blue text) arise from genetic mutations to indicated enzymes (grey). (B) GC‐MS analysis of human <t>fibroblasts</t> shows Smith–Lemli–Opitz syndrome (SLOS) and lathosterolosis (LATH) are cholesterol‐deficient and accumulate sterol precursors (mean ± SEM; n = 3 biological replicates from 3 independent experiments). (C) Small extracellular vesicle (sEV) release is elevated in SLOS and LATH fibroblasts relative to controls (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F2,9 = 10.22, p ≤ 0.0048), Dunnett's multiple comparisons (* p ≤ 0.05; ** p ≤ 0.005). (D) Nanoparticle tracking analysis (NTA) of sEV size from HEK293T, HaCaT and HMC3 cells (mean; n = 4 biological replicates from 4 independent experiments). (E) Representative transmission electron microscopy (TEM) image of sEVs isolated from HEK293T cells. Scale bar, 100 nm. (F) CD9 immunoblot in HEK293T‐isolated sEVs following treatment with respective cholesterol biosynthesis inhibition. (G) Inhibition of cholesterol biosynthesis in HEK293T cells results in increased sEV release (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F5,18 = 20.51, p < 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (H) Regression analysis of sEVs from HEK293T cells reveals a strong negative correlation between sEV secretion and cellular cholesterol levels. Linear regression (F1,4 = 15.17, R 2 = 0.7913, p ≤ 0.0176).
    Control Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1825 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control fibroblasts/product/ATCC
    Average 99 stars, based on 1825 article reviews
    control fibroblasts - by Bioz Stars, 2026-03
    99/100 stars

    Images

    1) Product Images from "Cholesterol Deficiency Directs Autophagy‐Dependent Secretion of Extracellular Vesicles"

    Article Title: Cholesterol Deficiency Directs Autophagy‐Dependent Secretion of Extracellular Vesicles

    Journal: Journal of Extracellular Vesicles

    doi: 10.1002/jev2.70218

    Cholesterol depletion promotes small extracellular vesicle release. (A) Cholesterol metabolic reactions targeted with small molecule inhibitors (red text). Rare diseases of cholesterol biosynthesis (blue text) arise from genetic mutations to indicated enzymes (grey). (B) GC‐MS analysis of human fibroblasts shows Smith–Lemli–Opitz syndrome (SLOS) and lathosterolosis (LATH) are cholesterol‐deficient and accumulate sterol precursors (mean ± SEM; n = 3 biological replicates from 3 independent experiments). (C) Small extracellular vesicle (sEV) release is elevated in SLOS and LATH fibroblasts relative to controls (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F2,9 = 10.22, p ≤ 0.0048), Dunnett's multiple comparisons (* p ≤ 0.05; ** p ≤ 0.005). (D) Nanoparticle tracking analysis (NTA) of sEV size from HEK293T, HaCaT and HMC3 cells (mean; n = 4 biological replicates from 4 independent experiments). (E) Representative transmission electron microscopy (TEM) image of sEVs isolated from HEK293T cells. Scale bar, 100 nm. (F) CD9 immunoblot in HEK293T‐isolated sEVs following treatment with respective cholesterol biosynthesis inhibition. (G) Inhibition of cholesterol biosynthesis in HEK293T cells results in increased sEV release (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F5,18 = 20.51, p < 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (H) Regression analysis of sEVs from HEK293T cells reveals a strong negative correlation between sEV secretion and cellular cholesterol levels. Linear regression (F1,4 = 15.17, R 2 = 0.7913, p ≤ 0.0176).
    Figure Legend Snippet: Cholesterol depletion promotes small extracellular vesicle release. (A) Cholesterol metabolic reactions targeted with small molecule inhibitors (red text). Rare diseases of cholesterol biosynthesis (blue text) arise from genetic mutations to indicated enzymes (grey). (B) GC‐MS analysis of human fibroblasts shows Smith–Lemli–Opitz syndrome (SLOS) and lathosterolosis (LATH) are cholesterol‐deficient and accumulate sterol precursors (mean ± SEM; n = 3 biological replicates from 3 independent experiments). (C) Small extracellular vesicle (sEV) release is elevated in SLOS and LATH fibroblasts relative to controls (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F2,9 = 10.22, p ≤ 0.0048), Dunnett's multiple comparisons (* p ≤ 0.05; ** p ≤ 0.005). (D) Nanoparticle tracking analysis (NTA) of sEV size from HEK293T, HaCaT and HMC3 cells (mean; n = 4 biological replicates from 4 independent experiments). (E) Representative transmission electron microscopy (TEM) image of sEVs isolated from HEK293T cells. Scale bar, 100 nm. (F) CD9 immunoblot in HEK293T‐isolated sEVs following treatment with respective cholesterol biosynthesis inhibition. (G) Inhibition of cholesterol biosynthesis in HEK293T cells results in increased sEV release (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F5,18 = 20.51, p < 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (H) Regression analysis of sEVs from HEK293T cells reveals a strong negative correlation between sEV secretion and cellular cholesterol levels. Linear regression (F1,4 = 15.17, R 2 = 0.7913, p ≤ 0.0176).

    Techniques Used: Gas Chromatography-Mass Spectrometry, Transmission Assay, Electron Microscopy, Isolation, Western Blot, Inhibition



    Similar Products

    99
    ATCC control fibroblasts
    Cholesterol depletion promotes small extracellular vesicle release. (A) Cholesterol metabolic reactions targeted with small molecule inhibitors (red text). Rare diseases of cholesterol biosynthesis (blue text) arise from genetic mutations to indicated enzymes (grey). (B) GC‐MS analysis of human <t>fibroblasts</t> shows Smith–Lemli–Opitz syndrome (SLOS) and lathosterolosis (LATH) are cholesterol‐deficient and accumulate sterol precursors (mean ± SEM; n = 3 biological replicates from 3 independent experiments). (C) Small extracellular vesicle (sEV) release is elevated in SLOS and LATH fibroblasts relative to controls (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F2,9 = 10.22, p ≤ 0.0048), Dunnett's multiple comparisons (* p ≤ 0.05; ** p ≤ 0.005). (D) Nanoparticle tracking analysis (NTA) of sEV size from HEK293T, HaCaT and HMC3 cells (mean; n = 4 biological replicates from 4 independent experiments). (E) Representative transmission electron microscopy (TEM) image of sEVs isolated from HEK293T cells. Scale bar, 100 nm. (F) CD9 immunoblot in HEK293T‐isolated sEVs following treatment with respective cholesterol biosynthesis inhibition. (G) Inhibition of cholesterol biosynthesis in HEK293T cells results in increased sEV release (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F5,18 = 20.51, p < 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (H) Regression analysis of sEVs from HEK293T cells reveals a strong negative correlation between sEV secretion and cellular cholesterol levels. Linear regression (F1,4 = 15.17, R 2 = 0.7913, p ≤ 0.0176).
    Control Fibroblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control fibroblasts/product/ATCC
    Average 99 stars, based on 1 article reviews
    control fibroblasts - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    95
    PromoCell control human pulmonary fibroblasts
    Relative mRNA expression levels of Axl, Tyro3, and Gas6 genes in IPF FBs and HPFs quantified by RT-qPCR. No Mer expression was detected in both <t>fibroblast</t> types. TBP gene was used as housekeeping gene. N = 4.
    Control Human Pulmonary Fibroblasts, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control human pulmonary fibroblasts/product/PromoCell
    Average 95 stars, based on 1 article reviews
    control human pulmonary fibroblasts - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    99
    ATCC control human dermal fibroblast cell line
    Mitochondrial respiration is impaired in <t>fibroblasts</t> derived from patients with DLD deficiency. Mitochondrial oxygen consumption was assessed in controls (Ctrl1 and Ctrl2) and patient (Pt1–Pt6) fibroblasts using high-resolution respirometry (Oroboros O2k). ( A ) Routine respiration; ( B ) maximal respiration calculated as the difference between FCCP-stimulated and α-chaconine–permeabilized rates; ( C ) complex I-linked respiration (NADH-linked respiration, N-pathway), calculated as the difference between ADP and α-chaconine; ( D ) complex II-linked respiration (NS-pathway) calculated as the difference between respiration after rotenone and α-chaconine addition; ( E ) effect of complex I inhibition, calculated as the difference between FCCP-stimulated and rotenone-inhibited respiration; and ( F ) complex I/complex II respiration ratio (complex I-linked activity divided by complex II-linked activity). Each open circle represents an independent experimental run (N = 4–8 repeats per sample). All data were normalized to cell number. Statistical analysis was performed using the Mann–Whitney U test. * p < 0.05 vs. Ctrl1; numerical p values (0.05 < p < 0.1) are indicated on the plots. Abbreviations: Ctrl, control; Pt, patient.
    Control Human Dermal Fibroblast Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control human dermal fibroblast cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    control human dermal fibroblast cell line - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    Coriell Institute for Medical Research control fibroblasts gm01652
    Mitochondrial respiration is impaired in <t>fibroblasts</t> derived from patients with DLD deficiency. Mitochondrial oxygen consumption was assessed in controls (Ctrl1 and Ctrl2) and patient (Pt1–Pt6) fibroblasts using high-resolution respirometry (Oroboros O2k). ( A ) Routine respiration; ( B ) maximal respiration calculated as the difference between FCCP-stimulated and α-chaconine–permeabilized rates; ( C ) complex I-linked respiration (NADH-linked respiration, N-pathway), calculated as the difference between ADP and α-chaconine; ( D ) complex II-linked respiration (NS-pathway) calculated as the difference between respiration after rotenone and α-chaconine addition; ( E ) effect of complex I inhibition, calculated as the difference between FCCP-stimulated and rotenone-inhibited respiration; and ( F ) complex I/complex II respiration ratio (complex I-linked activity divided by complex II-linked activity). Each open circle represents an independent experimental run (N = 4–8 repeats per sample). All data were normalized to cell number. Statistical analysis was performed using the Mann–Whitney U test. * p < 0.05 vs. Ctrl1; numerical p values (0.05 < p < 0.1) are indicated on the plots. Abbreviations: Ctrl, control; Pt, patient.
    Control Fibroblasts Gm01652, supplied by Coriell Institute for Medical Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control fibroblasts gm01652/product/Coriell Institute for Medical Research
    Average 90 stars, based on 1 article reviews
    control fibroblasts gm01652 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    99
    ATCC control group
    Mitochondrial respiration is impaired in <t>fibroblasts</t> derived from patients with DLD deficiency. Mitochondrial oxygen consumption was assessed in controls (Ctrl1 and Ctrl2) and patient (Pt1–Pt6) fibroblasts using high-resolution respirometry (Oroboros O2k). ( A ) Routine respiration; ( B ) maximal respiration calculated as the difference between FCCP-stimulated and α-chaconine–permeabilized rates; ( C ) complex I-linked respiration (NADH-linked respiration, N-pathway), calculated as the difference between ADP and α-chaconine; ( D ) complex II-linked respiration (NS-pathway) calculated as the difference between respiration after rotenone and α-chaconine addition; ( E ) effect of complex I inhibition, calculated as the difference between FCCP-stimulated and rotenone-inhibited respiration; and ( F ) complex I/complex II respiration ratio (complex I-linked activity divided by complex II-linked activity). Each open circle represents an independent experimental run (N = 4–8 repeats per sample). All data were normalized to cell number. Statistical analysis was performed using the Mann–Whitney U test. * p < 0.05 vs. Ctrl1; numerical p values (0.05 < p < 0.1) are indicated on the plots. Abbreviations: Ctrl, control; Pt, patient.
    Control Group, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/control group/product/ATCC
    Average 99 stars, based on 1 article reviews
    control group - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    90
    Copernic Technologies Inc radioresistant control copernic fibroblasts
    Mitochondrial respiration is impaired in <t>fibroblasts</t> derived from patients with DLD deficiency. Mitochondrial oxygen consumption was assessed in controls (Ctrl1 and Ctrl2) and patient (Pt1–Pt6) fibroblasts using high-resolution respirometry (Oroboros O2k). ( A ) Routine respiration; ( B ) maximal respiration calculated as the difference between FCCP-stimulated and α-chaconine–permeabilized rates; ( C ) complex I-linked respiration (NADH-linked respiration, N-pathway), calculated as the difference between ADP and α-chaconine; ( D ) complex II-linked respiration (NS-pathway) calculated as the difference between respiration after rotenone and α-chaconine addition; ( E ) effect of complex I inhibition, calculated as the difference between FCCP-stimulated and rotenone-inhibited respiration; and ( F ) complex I/complex II respiration ratio (complex I-linked activity divided by complex II-linked activity). Each open circle represents an independent experimental run (N = 4–8 repeats per sample). All data were normalized to cell number. Statistical analysis was performed using the Mann–Whitney U test. * p < 0.05 vs. Ctrl1; numerical p values (0.05 < p < 0.1) are indicated on the plots. Abbreviations: Ctrl, control; Pt, patient.
    Radioresistant Control Copernic Fibroblasts, supplied by Copernic Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/radioresistant control copernic fibroblasts/product/Copernic Technologies Inc
    Average 90 stars, based on 1 article reviews
    radioresistant control copernic fibroblasts - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Coriell Institute for Medical Research skin fibroblasts wild-type (wt) control
    Mitochondrial respiration is impaired in <t>fibroblasts</t> derived from patients with DLD deficiency. Mitochondrial oxygen consumption was assessed in controls (Ctrl1 and Ctrl2) and patient (Pt1–Pt6) fibroblasts using high-resolution respirometry (Oroboros O2k). ( A ) Routine respiration; ( B ) maximal respiration calculated as the difference between FCCP-stimulated and α-chaconine–permeabilized rates; ( C ) complex I-linked respiration (NADH-linked respiration, N-pathway), calculated as the difference between ADP and α-chaconine; ( D ) complex II-linked respiration (NS-pathway) calculated as the difference between respiration after rotenone and α-chaconine addition; ( E ) effect of complex I inhibition, calculated as the difference between FCCP-stimulated and rotenone-inhibited respiration; and ( F ) complex I/complex II respiration ratio (complex I-linked activity divided by complex II-linked activity). Each open circle represents an independent experimental run (N = 4–8 repeats per sample). All data were normalized to cell number. Statistical analysis was performed using the Mann–Whitney U test. * p < 0.05 vs. Ctrl1; numerical p values (0.05 < p < 0.1) are indicated on the plots. Abbreviations: Ctrl, control; Pt, patient.
    Skin Fibroblasts Wild Type (Wt) Control, supplied by Coriell Institute for Medical Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/skin fibroblasts wild-type (wt) control/product/Coriell Institute for Medical Research
    Average 90 stars, based on 1 article reviews
    skin fibroblasts wild-type (wt) control - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Cholesterol depletion promotes small extracellular vesicle release. (A) Cholesterol metabolic reactions targeted with small molecule inhibitors (red text). Rare diseases of cholesterol biosynthesis (blue text) arise from genetic mutations to indicated enzymes (grey). (B) GC‐MS analysis of human fibroblasts shows Smith–Lemli–Opitz syndrome (SLOS) and lathosterolosis (LATH) are cholesterol‐deficient and accumulate sterol precursors (mean ± SEM; n = 3 biological replicates from 3 independent experiments). (C) Small extracellular vesicle (sEV) release is elevated in SLOS and LATH fibroblasts relative to controls (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F2,9 = 10.22, p ≤ 0.0048), Dunnett's multiple comparisons (* p ≤ 0.05; ** p ≤ 0.005). (D) Nanoparticle tracking analysis (NTA) of sEV size from HEK293T, HaCaT and HMC3 cells (mean; n = 4 biological replicates from 4 independent experiments). (E) Representative transmission electron microscopy (TEM) image of sEVs isolated from HEK293T cells. Scale bar, 100 nm. (F) CD9 immunoblot in HEK293T‐isolated sEVs following treatment with respective cholesterol biosynthesis inhibition. (G) Inhibition of cholesterol biosynthesis in HEK293T cells results in increased sEV release (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F5,18 = 20.51, p < 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (H) Regression analysis of sEVs from HEK293T cells reveals a strong negative correlation between sEV secretion and cellular cholesterol levels. Linear regression (F1,4 = 15.17, R 2 = 0.7913, p ≤ 0.0176).

    Journal: Journal of Extracellular Vesicles

    Article Title: Cholesterol Deficiency Directs Autophagy‐Dependent Secretion of Extracellular Vesicles

    doi: 10.1002/jev2.70218

    Figure Lengend Snippet: Cholesterol depletion promotes small extracellular vesicle release. (A) Cholesterol metabolic reactions targeted with small molecule inhibitors (red text). Rare diseases of cholesterol biosynthesis (blue text) arise from genetic mutations to indicated enzymes (grey). (B) GC‐MS analysis of human fibroblasts shows Smith–Lemli–Opitz syndrome (SLOS) and lathosterolosis (LATH) are cholesterol‐deficient and accumulate sterol precursors (mean ± SEM; n = 3 biological replicates from 3 independent experiments). (C) Small extracellular vesicle (sEV) release is elevated in SLOS and LATH fibroblasts relative to controls (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F2,9 = 10.22, p ≤ 0.0048), Dunnett's multiple comparisons (* p ≤ 0.05; ** p ≤ 0.005). (D) Nanoparticle tracking analysis (NTA) of sEV size from HEK293T, HaCaT and HMC3 cells (mean; n = 4 biological replicates from 4 independent experiments). (E) Representative transmission electron microscopy (TEM) image of sEVs isolated from HEK293T cells. Scale bar, 100 nm. (F) CD9 immunoblot in HEK293T‐isolated sEVs following treatment with respective cholesterol biosynthesis inhibition. (G) Inhibition of cholesterol biosynthesis in HEK293T cells results in increased sEV release (mean ± SEM; n = 4 biological replicates from 4 independent experiments). One‐way ANOVA (F5,18 = 20.51, p < 0.0001), Dunnett's multiple comparisons test (** p ≤ 0.005, **** p < 0.0001). (H) Regression analysis of sEVs from HEK293T cells reveals a strong negative correlation between sEV secretion and cellular cholesterol levels. Linear regression (F1,4 = 15.17, R 2 = 0.7913, p ≤ 0.0176).

    Article Snippet: Control fibroblasts were purchased commercially (ATCC, CRL‐2522).

    Techniques: Gas Chromatography-Mass Spectrometry, Transmission Assay, Electron Microscopy, Isolation, Western Blot, Inhibition

    Relative mRNA expression levels of Axl, Tyro3, and Gas6 genes in IPF FBs and HPFs quantified by RT-qPCR. No Mer expression was detected in both fibroblast types. TBP gene was used as housekeeping gene. N = 4.

    Journal: Medicina

    Article Title: Evaluation of TAM Receptor Targeting in Pathophysiology of Idiopathic Pulmonary Fibrosis

    doi: 10.3390/medicina61101837

    Figure Lengend Snippet: Relative mRNA expression levels of Axl, Tyro3, and Gas6 genes in IPF FBs and HPFs quantified by RT-qPCR. No Mer expression was detected in both fibroblast types. TBP gene was used as housekeeping gene. N = 4.

    Article Snippet: Control human pulmonary fibroblasts (HPFs, C12360 , PromoCell, St. Louis, MO, USA) were cultured in 25 mM glucose DMEM supplemented with 10% FBS and 1% penicillin/streptomycin solution, and cells were used between passages 7 and 15.

    Techniques: Expressing, Quantitative RT-PCR

    Mitochondrial respiration is impaired in fibroblasts derived from patients with DLD deficiency. Mitochondrial oxygen consumption was assessed in controls (Ctrl1 and Ctrl2) and patient (Pt1–Pt6) fibroblasts using high-resolution respirometry (Oroboros O2k). ( A ) Routine respiration; ( B ) maximal respiration calculated as the difference between FCCP-stimulated and α-chaconine–permeabilized rates; ( C ) complex I-linked respiration (NADH-linked respiration, N-pathway), calculated as the difference between ADP and α-chaconine; ( D ) complex II-linked respiration (NS-pathway) calculated as the difference between respiration after rotenone and α-chaconine addition; ( E ) effect of complex I inhibition, calculated as the difference between FCCP-stimulated and rotenone-inhibited respiration; and ( F ) complex I/complex II respiration ratio (complex I-linked activity divided by complex II-linked activity). Each open circle represents an independent experimental run (N = 4–8 repeats per sample). All data were normalized to cell number. Statistical analysis was performed using the Mann–Whitney U test. * p < 0.05 vs. Ctrl1; numerical p values (0.05 < p < 0.1) are indicated on the plots. Abbreviations: Ctrl, control; Pt, patient.

    Journal: Antioxidants

    Article Title: Bioenergetic Signatures of DLD Deficiency: Dissecting PDHc- and α-KGDHc-Linked Defects

    doi: 10.3390/antiox15010019

    Figure Lengend Snippet: Mitochondrial respiration is impaired in fibroblasts derived from patients with DLD deficiency. Mitochondrial oxygen consumption was assessed in controls (Ctrl1 and Ctrl2) and patient (Pt1–Pt6) fibroblasts using high-resolution respirometry (Oroboros O2k). ( A ) Routine respiration; ( B ) maximal respiration calculated as the difference between FCCP-stimulated and α-chaconine–permeabilized rates; ( C ) complex I-linked respiration (NADH-linked respiration, N-pathway), calculated as the difference between ADP and α-chaconine; ( D ) complex II-linked respiration (NS-pathway) calculated as the difference between respiration after rotenone and α-chaconine addition; ( E ) effect of complex I inhibition, calculated as the difference between FCCP-stimulated and rotenone-inhibited respiration; and ( F ) complex I/complex II respiration ratio (complex I-linked activity divided by complex II-linked activity). Each open circle represents an independent experimental run (N = 4–8 repeats per sample). All data were normalized to cell number. Statistical analysis was performed using the Mann–Whitney U test. * p < 0.05 vs. Ctrl1; numerical p values (0.05 < p < 0.1) are indicated on the plots. Abbreviations: Ctrl, control; Pt, patient.

    Article Snippet: Dermal fibroblast primary cell lines from six genetically confirmed patients with DLD deficiency were obtained from the Pediatric Metabolic Disease Unit, Sheba Medical Center (IRB# SMC-21-8644, Figure 1, Table 1, and ), as well as two control cell lines: a control human dermal fibroblast cell line was purchased from ATCC (PCS-201-012; Ctrl 1, Manassas, VA, USA), and a primary cell line from a 39-year-old healthy male (Ctrl 2).

    Techniques: Derivative Assay, Inhibition, Activity Assay, MANN-WHITNEY, Control